Literature DB >> 32203394

New insights into very-late-onset myasthenia gravis.

Carolina Barnett1, Vera Bril2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32203394     DOI： 10.1038/s41582-020-0345-3

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  Antibodies against nodo-paranodal proteins are not present in genetic neuropathies.

Authors:  Lorena Martín-Aguilar; Elba Pascual-Goñi; Cinta Lleixà; Marina Frasquet; Herminia Argente; Angel Cano-Abascal; Jordi Diaz-Manera; Elena Cortés-Vicente; Ana Lara Pelayo-Negro; Teresa Sevilla; Ricard Rojas-García; Luis Querol
Journal:  Neurology       Date:  2020-02-26       Impact factor: 9.910

2.  Employment in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis.

Authors:  Erika Guastafierro; Irene Tramacere; Claudia Toppo; Matilde Leonardi; Renato Mantegazza; Silvia Bonanno; Rita Frangiamore; Alberto Raggi
Journal:  Neuroepidemiology       Date:  2020-02-25       Impact factor: 3.282
  2 in total
  3 in total

1.  Clinical Features of Myasthenia Gravis With Antibodies to MuSK Based on Age at Onset: A Multicenter Retrospective Study in China.

Authors:  Yufan Zhou; Jialin Chen; Zunbo Li; Song Tan; Chong Yan; Sushan Luo; Lei Zhou; Jie Song; Xiao Huan; Ying Wang; Chongbo Zhao; Wenshuang Zeng; Jianying Xi
Journal:  Front Neurol       Date:  2022-04-08       Impact factor: 4.003

2.  Efficacy and Safety of Tacrolimus Therapy for a Single Chinese Cohort With Very-Late-Onset Myasthenia Gravis.

Authors:  Yiming Zheng; Xiaoqiu Yuan; Caifeng Zhang; Ran Liu; Haiqiang Jin; Hongjun Hao; Fan Li; Yawen Zhao; Yun Yuan; Zhaoxia Wang; Feng Gao
Journal:  Front Neurol       Date:  2022-03-30       Impact factor: 4.003

3.  Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset.

Authors:  Sijia Zhao; Xu Yan; Jiaqi Ding; Kaixi Ren; Shuyu Sun; Jiarui Lu; Chao Zhang; Kai Zhang; Zhuyi Li; Jun Guo
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.086
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.